scholarly journals A Double-Deck Structure of Reduced Graphene Oxide Modified Porous Ti3C2Tx Electrode towards Ultrasensitive and Simultaneous Detection of Dopamine and Uric Acid

Biosensors ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 462
Author(s):  
Yangguang Zhu ◽  
Qichen Tian ◽  
Xiufen Li ◽  
Lidong Wu ◽  
Aimin Yu ◽  
...  
Keyword(s):  
Uric Acid ◽  
Graphene Oxide ◽  
Detection Limit ◽  
Debye Length ◽  
Simultaneous Detection ◽  
Sample Analysis ◽  
Excellent Performance ◽  
Real Sample Analysis ◽  
Reduced Graphene ◽  
Good Repeatability

Considering the vital physiological functions of dopamine (DA) and uric acid (UA) and their coexistence in the biological matrix, the development of biosensing techniques for their simultaneous and sensitive detection is highly desirable for diagnostic and analytical applications. Therefore, Ti3C2Tx/rGO heterostructure with a double-deck layer was fabricated through electrochemical reduction. The rGO was modified on a porous Ti3C2Tx electrode as the biosensor for the detection of DA and UA simultaneously. Debye length was regulated by the alteration of rGO mass on the surface of the Ti3C2Tx electrode. Debye length decreased with respect to the rGO electrode modified with further rGO mass, indicating that fewer DA molecules were capable of surpassing the equilibrium double layer and reaching the surface of rGO to achieve the voltammetric response of DA. Thus, the proposed Ti3C2Tx/rGO sensor presented an excellent performance in detecting DA and UA with a wide linear range of 0.1–100 μM and 1–1000 μM and a low detection limit of 9.5 nM and 0.3 μM, respectively. Additionally, the proposed Ti3C2Tx/rGO electrode displayed good repeatability, selectivity, and proved to be available for real sample analysis.

scholarly journals N-Doped Reduced Graphene Oxide/Gold Nanoparticles Composite as an Improved Sensing Platform for Simultaneous Detection of Dopamine, Ascorbic Acid, and Uric Acid

Sensors ◽  
2020 ◽  
Vol 20 (16) ◽  
pp. 4427
Author(s):  
Daria Minta ◽  
Zoraida González ◽  
Piotr Wiench ◽  
Stanisław Gryglewicz ◽  
Grażyna Gryglewicz
Keyword(s):  
Gold Nanoparticles ◽  
Ascorbic Acid ◽  
Uric Acid ◽  
Graphene Oxide ◽  
Detection Limit ◽  
Electrochemical Performance ◽  
Reduced Graphene Oxide ◽  
Simultaneous Detection ◽  
Homogeneous Distribution ◽  
Reduced Graphene

Gold nanoparticles (AuNPs) were homogeneously electrodeposited on nitrogen-doped reduced graphene oxide (N-rGO) to modify a glassy carbon electrode (GCE/N-rGO-Au) in order to improve the simultaneous detection of dopamine (DA), ascorbic acid (AA), and uric acid (UA). N-rGO was prepared by the hydrothermal treatment of graphene oxide (GO) and urea at 180 °C for 12 h. AuNPs were subsequently electrodeposited onto the surface of GCE/N-rGO using 1 mM HAuCl4 solution. The morphology and chemical composition of the synthesized materials were characterized by field-emission scanning electron microscopy and X-ray photoelectron spectroscopy. The electrochemical performance of the modified electrodes was investigated through cyclic voltammetry and differential pulse voltammetry measurements. Compared to GCE/rGO-Au, GCE/N-rGO-Au exhibited better electrochemical performance towards the simultaneous detection of the three analytes due to the more homogeneous distribution of the metallic nanoparticles as a result of more efficient anchoring on the N-doped areas of the graphene structure. The GCE/N-rGO-Au-based sensor operated in a wide linear range of DA (3–100 µM), AA (550–1500 µM), and UA (20–1000 µM) concentrations with a detection limit of 2.4, 58, and 8.7 µM, respectively, and exhibited satisfactory peak potential separation values of 0.34 V (AA-DA), 0.20 V, (DA-UA) and 0.54 V (AA-UA). Remarkably, GCE/N-rGO-Au showed a very low detection limit of 385 nM towards DA, not being susceptible to interference, and maintained 90% of its initial electrochemical signal after one month, indicating an excellent long-term stability.

scholarly journals Reduced Graphene Oxide Carbon Yarn Electrodes for Drug Sensing

2021 ◽  
Vol 2 ◽  
Author(s):  
Sutthima Sriprasertsuk ◽  
Shuai Zhang ◽  
Gordon Wallace ◽  
Jun Chen ◽  
John R. Varcoe ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Detection Limit ◽  
Carbon Fibre ◽  
Reduced Graphene Oxide ◽  
Simultaneous Detection ◽  
Differential Pulse ◽  
Reduced Graphene ◽  
Electrochemically Deposited ◽  
Pulse Voltammetry

A modified carbon fibre yarn sensor was developed for the voltammetric determination of paracetamol and its interferents (dopamine and ascorbic acid). Reduced graphene oxide (rGO) was electrochemically deposited onto a carbon fibre yarn. Further modification was achieved using polypyrrole (PPy) coated onto the rGO carbon fibre yarn via electropolymerisation of pyrrole with cyclic voltammetry (CV). The surface of the rGO and PPy-rGO carbon fibre electrodes were characterised using Raman spectroscopy and scanning electron microscopy. The rGO and PPy-rGO carbon fibres had a 3.5-fold and 7-fold larger electrochemical surface area compared to bare carbon fibre (calculated using the Randles-Sevcik equation). Two clearly distinguished oxidation peaks at 0.49 and 0.25 V (vs. Ag/AgCl) were observed at the rGO fibre electrode during the simultaneous detection of paracetamol and dopamine, respectively, by CV. The detection limit (3σ S/N) of the rGO carbon fibre electrode for differential pulse voltammetry (DPV) determination of paracetamol was at 21.1 and 6.0 µM for dopamine. In comparison, the simultaneous determination of paracetamol and dopamine by CV at the PPy-rGO fibre electrode gave oxidation peaks of paracetamol and dopamine at 0.55 and 0.25 V (vs. Ag/AgCl), respectively. The detection limit (3σ S/N) for paracetamol was notably improved to 3.7 µM and maintained at 6.0 µM for dopamine at the PPy-rGO carbon fibre electrode during DPV.

scholarly journals SIMULTANEOUS ELECTROCHEMICAL DETECTION OF ASCORBIC ACID, DOPAMINE, AND URIC ACID AT MAGNETIC NANOPARTICLES/REDUCED GRAPHENE OXIDE MODIFIED ELECTRODE

2021 ◽  
Vol 83 (3) ◽  
pp. 85-92
Author(s):  
Azleen Rashidah Mohd Rosli ◽  
Farhanini Yusoff ◽  
Saw Hong Loh ◽  
Hanis Mohd Yusoff ◽  
Muhammad Mahadi Abdul Jamil ◽  
...  
Keyword(s):  
Ascorbic Acid ◽  
Uric Acid ◽  
Graphene Oxide ◽  
Magnetic Nanoparticles ◽  
Reduced Graphene Oxide ◽  
Modified Electrode ◽  
Limit Of Detection ◽  
Simultaneous Detection ◽  
Differential Pulse ◽  
Reduced Graphene

A magnetic nanoparticles/reduced graphene oxide modified glassy carbon electrode (MNP/rGO/GCE) was fabricated via one-step facile synthesis route for the simultaneous determination of ascorbic acid (AA), dopamine (DA), along with uric acid (UA). A series of diseases and disorders has been associated with irregular levels of these respective analytes, thus early detection is highly crucial. Physical and electrochemical characterization of the modified electrode was conducted by using Scanning Electron Microscopy (SEM), Fourier Transform Infrared (FTIR) analysis, X-Ray Diffraction (XRD) analysis and Brauneur-Emmet-Teller (BET), Cyclic Voltammetry (CV) and Electron Impedance Spectroscopy (EIS). The results obtained confirmed the formation of MNP/rGO composite. Differential pulse voltammetry (DPV) of MNP/rGO/GCE displays three well-defined peaks which associated to AA, DA and UA, respectively. The response towards DA is linear in the concentration range of 15 nM to 100 µM with a detection limit of 0.19 nM while a response to AA and UA is also linear in the concentration range of 10 µM to 100 µM with a limit of detection 0.22 µM and 45 nM respectively. The proposed modified electrode offers a good response towards simultaneous detection of three different electroactive species with excellent electron transfer rate, great capacitance and ideal diffusive control behavior.

scholarly journals Nanocomposite Based on Poly (para-phenylene)/Chemical Reduced Graphene Oxide as a Platform for Simultaneous Detection of Ascorbic Acid, Dopamine and Uric Acid

Sensors ◽  
2020 ◽  
Vol 20 (5) ◽  
pp. 1256 ◽  
Author(s):  
Zouhour Hsine ◽  
Salma Bizid ◽  
Rym Mlika ◽  
Hélène Sauriat-Dorizon ◽  
Ayoub Haj Said ◽  
...  
Keyword(s):  
Ascorbic Acid ◽  
Uric Acid ◽  
Graphene Oxide ◽  
Reduced Graphene Oxide ◽  
Linear Response ◽  
Catalytic Properties ◽  
Simultaneous Detection ◽  
Lateral Position ◽  
Reduced Graphene

In this study, an efficient and simple designed nanohybrid created for individual and simultaneous detection of ascorbic acid (AA), dopamine (DA) and uric acid (UA). This nanohybrid is a combination of chemical reduced graphene oxide (CRGO) and redox poly(para-phenylene) (Fc-ac-PP) modified in a lateral position with ferrrocenyl group CRGO/Fc-ac-PPP. The CRGO/Fc-ac-PPP nanohybrid demonstrated a synergistic effect resulting in a large conductivity, surface area and catalytic properties provided by the redox attached ferrocene. Moreover, this nanocomposite is able to detect individually as well as simultaneously AA, DA and UA in a co-existence system with defined and separated redox peaks oxidation. The linear response ranges for AA, DA and UA, when detected simultaneously, are 0.1–10000 μM, 0.0001–1000 μM and 0.1–10000 μM, respectively, and the detection limits (S/N = 3) are 0.046 μM, 0.2 nM and 0.013 μM, respectively. The proposed sensor shown satisfactory results when applied to real spiked urine samples for measuring the abnormal high or lowconcentration of AA, DA and UA in vivo.

scholarly journals Disposable Nonenzymatic Uric Acid and Creatinine Sensors Using μPAD Coupled with Screen-Printed Reduced Graphene Oxide-Gold Nanocomposites

2019 ◽  
Vol 2019 ◽  
pp. 1-11 ◽  
Author(s):  
Kamolwich Income ◽  
Nalin Ratnarathorn ◽  
Napassawan Khamchaiyo ◽  
Chanut Srisuvo ◽  
Leela Ruckthong ◽  
...  
Keyword(s):  
Uric Acid ◽  
Graphene Oxide ◽  
Detection Limit ◽  
Reduced Graphene Oxide ◽  
Reduced Graphene ◽  
Uric Acid Nephropathy ◽  
Acute Uric Acid Nephropathy ◽  
Gold Nanocomposites ◽  
Screen Printed

Uric acid (UA) and creatinine are the imperative biological substance for clinical monitoring and diagnosis. Measuring the ratio between uric acid and creatinine in urine helps differentiate acute uric acid nephropathy from the hyperuricemia that secondarily occurs to renal failure. In general, the ratio is greater than 0.9 in acute uric acid nephropathy and less than 0.7 in hyperuricemia. In this work, disposable nonenzymatic screen-printed reduced graphene oxide-gold nanocomposites electrodes were firstly developed for the quantitative analysis of uric acid. Our sensors were also coupled with the paper-based colorimetric sensor of the determination of creatinine. Hence, an alternative high-throughput screening test for the uric acid to creatinine ratio with high sensitivity, specificity, simplicity, and rapidity was developed. Under the optimum conditions, our disposable nonenzymatic screen-printed electrode for the determination of uric acid shows the acceptable analytical performance in a wide range of linearity (2.5-1,000 μM) with a low detection limit of 0.74 μM. Our electrodes also showed no interference from common physiologic compound in urine. The determination of creatinine has been developed using Jaffé reaction between the creatinine and picric acid in alkaline condition. The alkaline picrate color on μPAD changed from yellow to orange in the presence of creatinine and the orange intensity is directly proportional to the creatinine amount in a linearity range of 0.20-6.0 mM as a detection limit of 180 μM. Finally, our device has been utilized to determine uric acid and creatinine simultaneously in control urine samples with acceptable result.

Sign in / Sign up

Export Citation Format

Share Document